Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes
Kappos, L, Polman, C H, Freedman, M S, Edan, G, Hartung, H P, Miller, D H, Montalban, X, Barkhof, F, Bauer, L, Jakobs, P, Pohl, C, Sandbrink, R
Published in Neurology (10.10.2006)
Published in Neurology (10.10.2006)
Get more information
Journal Article
Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT
Edan, G, Kappos, L, Montalbán, X, Polman, C H, Freedman, M S, Hartung, H-P, Miller, D, Barkhof, F, Herrmann, J, Lanius, V, Stemper, B, Pohl, C, Sandbrink, R, Pleimes, D
Published in Journal of neurology, neurosurgery and psychiatry (01.11.2014)
Published in Journal of neurology, neurosurgery and psychiatry (01.11.2014)
Get full text
Journal Article
Interferon β-1b-neutralizing antibodies 5 years after clinically isolated syndrome
Hartung, H-P, Freedman, M S, Polman, C H, Edan, G, Kappos, L, Miller, D H, Montalbán, X, Barkhof, F, Petkau, J, White, R, Sahajpal, V, Knappertz, V, Beckmann, K, Lanius, V, Sandbrink, R, Pohl, C
Published in Neurology (30.08.2011)
Published in Neurology (30.08.2011)
Get more information
Journal Article
Blockade of chemokine signaling in patients with multiple sclerosis
Zipp, F, Hartung, H P, Hillert, J, Schimrigk, S, Trebst, C, Stangel, M, Infante-Duarte, C, Jakobs, P, Wolf, C, Sandbrink, R, Pohl, C, Filippi, M
Published in Neurology (28.11.2006)
Published in Neurology (28.11.2006)
Get more information
Journal Article
Evaluation of soluble HLA-G as a biomarker for multiple sclerosis
Waschbisch, A, Sandbrink, R, Hartung, H-P, Kappos, L, Schwab, S, Pohl, C, Wiendl, H
Published in Neurology (09.08.2011)
Published in Neurology (09.08.2011)
Get more information
Journal Article
Subgroups of the BENEFIT study: Risk of developing MS and treatment effect of interferon beta-1b
Polman, C., Kappos, L., Freedman, M. S., Edan, G., Hartung, H.-P., Miller, D. H., Montalbán, X., Barkhof, F., Selmaj, K., Uitdehaag, B. M. J., Dahms, S., Bauer, L., Pohl, C., Sandbrink, R.
Published in Journal of neurology (01.04.2008)
Published in Journal of neurology (01.04.2008)
Get full text
Journal Article
Lesional magnetization transfer ratio: a feasible outcome for remyelinating treatment trials in multiple sclerosis
van den Elskamp, IJ, Knol, DL, Vrenken, H., Karas, G., Meijerman, A., Filippi, M., Kappos, L., Fazekas, F., Wagner, K., Pohl, C., Sandbrink, R., Polman, CH, Uitdehaag, BMJ, Barkhof, F.
Published in Multiple sclerosis (01.06.2010)
Published in Multiple sclerosis (01.06.2010)
Get full text
Journal Article
Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysis
Freedman, MS, Metzig, C, Kappos, L, Polman, CH, Edan, G, Hartung, H-P, Miller, DH, Montalban, X, Yarden, J, Spector, L, Fire, E, Dotan, N, Schwenke, S, Lanius, V, Sandbrink, R, Pohl, C
Published in Multiple sclerosis (01.07.2012)
Published in Multiple sclerosis (01.07.2012)
Get full text
Journal Article
Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis
van den Elskamp, I. J., Boden, B., Dattola, V., Knol, D. L., Filippi, M., Kappos, L., Fazekas, F., Wagner, K., Pohl, C., Sandbrink, R., Polman, C. H., Uitdehaag, B. M. J., Barkhof, F.
Published in Neuroradiology (01.10.2010)
Published in Neuroradiology (01.10.2010)
Get full text
Journal Article
Persistent T1 hypointensity as an MRI marker for treatment efficacy in multiple sclerosis
van den Elskamp, IJ, Lembcke, J, Dattola, V, Beckmann, K, Pohl, C, Hong, W, Sandbrink, R, Wagner, K, Knol, DL, Uitdehaag, B, Barkhof, F
Published in Multiple sclerosis (01.07.2008)
Published in Multiple sclerosis (01.07.2008)
Get full text
Journal Article
Benefit 11: Long-term follow-up study of patients with clinically isolated syndrome treated with interferon beta-1b
Kappos, L, Edan, G, Freedman, M, Montalbán, X, Miller, D, Polman, C, Hartung, H.-P, Hemmer, B, Fox, E, Barkhof, F, Schippling, S, Lanius, V, Hermann, J, Pohl, C, Sandbrink, R, Wicklein, E.-M, Pleimes, D
Published in Journal of the neurological sciences (15.10.2013)
Published in Journal of the neurological sciences (15.10.2013)
Get full text
Journal Article
Can the functional assessment of multiple sclerosis adapt to changing needs? A psychometric validation in patients with clinically isolated syndrome and early relapsing–remitting multiple sclerosis
Acaster, S, Swinburn, P, Wang, C, Stemper, B, Beckmann, K, Knappertz, V, Pohl, C, Sandbrink, R, Gondek, K, Edan, G, Kappos, L, Freedman, M, Hartung, H-P, Arnason, B, Comi, G, Filippi, M, Jeffery, D, O’Connor, P, Cook, S, Lloyd, AJ
Published in Multiple sclerosis (01.12.2011)
Published in Multiple sclerosis (01.12.2011)
Get full text
Journal Article
Genes contributing to Alzheimer's disease
Sandbrink, R, Hartmann, T, Masters, C L, Beyreuther, K
Published in Molecular psychiatry (01.03.1996)
Get more information
Published in Molecular psychiatry (01.03.1996)
Journal Article
APP gene family. Alternative splicing generates functionally related isoforms
Sandbrink, R, Masters, C L, Beyreuther, K
Published in Annals of the New York Academy of Sciences (01.01.1996)
Published in Annals of the New York Academy of Sciences (01.01.1996)
Get more information
Journal Article
FP36-WE-06 Evaluation of efficacy, safety and tolerability of interferon beta 1b in patients of Chinese origin with multiple sclerosis
Lv, C, Zhang, X.H, Cui, L.Y, Xu, X.H, Radue, E.W, Wang, L.R, Beckmann, K, Lampe, J, Pohl, C, Stemper, B, Sandbrink, R
Published in Journal of the neurological sciences (2009)
Published in Journal of the neurological sciences (2009)
Get full text
Journal Article
Elements of informed consent for pharmacogenetic research; perspective of the pharmacogenetics working group
ANDERSON, D. C, GOMEZ-MANCILLA, B, MCHALE, D, HASHIMOTO, L, SANDBRINK, R, WATSON, M. L, SALERNO, R. A, COHEN, N, LISTER, C. E, SPEAR, B. B, BARNES, D. M, CHEESEMAN, K, SHAW, P. M, FRIEDMAN, J, MCCARTHY, A, BRAZELL, C, RAY, S. C
Published in The pharmacogenomics journal (2002)
Published in The pharmacogenomics journal (2002)
Get full text
Journal Article
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes
Kappos, L, Polman, C.H, Freedman, M.S, Edan, G, Hartung, H.P, Miller, D.H, Montalban, X, Barkhof, F, Bauer, L, Jakobs, P, Pohl, C, Sandbrink, R
Published in American journal of ophthalmology (2007)
Published in American journal of ophthalmology (2007)
Get full text
Journal Article
Oral interferon beta-1a in relapsing-remitting multiple sclerosis: a double-blind randomized study
Polman, C, Barkhof, F, Kappos, L, Pozzilli, C, Sandbrink, R, Dahlke, F, Jakobs, P, Lorenz, A
Published in Multiple sclerosis (01.08.2003)
Published in Multiple sclerosis (01.08.2003)
Get full text
Journal Article
Classification of patients with a clinically isolated syndrome based on signs and symptoms is supported by magnetic resonance imaging results
Nielsen, J.M., Moraal, B., Polman, C.H., Poppe, P., de Vos, M., Freedman, M.S., Kappos, L., Barkhof, F., Bauer, L., Pohl, C., Sandbrink, R., Hartung, H.-P., Uitdehaag, B.M.J.
Published in Multiple sclerosis (01.07.2007)
Published in Multiple sclerosis (01.07.2007)
Get full text
Journal Article